General Information of the Compound
Compound ID
CP0410200
Compound Name
2-methyl-5-[5-(4-piperidin-1-ylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-1,3-benzoxazole
    Show/Hide
Structure
Formula
C20H25N5OS
Molecular Weight
383.521
Canonical SMILES
Cc1nc2cc(ccc2o1)-c1nnc(s1)N1CCC(CC1)N1CCCCC1
    Show/Hide
InChI
InChI=1S/C20H25N5OS/c1-14-21-17-13-15(5-6-18(17)26-14)19-22-23-20(27-19)25-11-7-16(8-12-25)24-9-3-2-4-10-24/h5-6,13,16H,2-4,7-12H2,1H3
    Show/Hide
InChIKey
UWKLENCDKKIQFX-UHFFFAOYSA-N
Physicochemical Property
logP
4.10942
Rotatable Bonds
3
Heavy Atom Count
27
Polar Areas
58.29
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 70694267
ChEMBL ID
CHEMBL2031603
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 24.5 nM
   TI
   LI
   LO
   TS